These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 819202)

  • 21. [Treatment of cerebral vascular insufficiency syndromes in old age. Controlled research by double blind technic].
    Mars G; Nebuloni G
    G Gerontol; 1970 Mar; 18(3):153-76. PubMed ID: 4919664
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E; Di Lorenzo L; De Pergola G
    G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
    [No Abstract]   [Full Text] [Related]  

  • 23. [Trial of eutergine in chronic cerebral arteriopathies].
    Pauchant M; Bernard JM
    Lille Med; 1972 May; 17():Suppl 4:819-23. PubMed ID: 4626797
    [No Abstract]   [Full Text] [Related]  

  • 24. [Headaches in patients with vascular deficiency and their treatment with a raubasine-dihydroergocristine association].
    Henry P
    Bord Med; 1972 Nov; 5(18):2531-4. PubMed ID: 4196611
    [No Abstract]   [Full Text] [Related]  

  • 25. [Double-blind study based upon a quatitative appreciation scale of treating chronic cerebrovascular disorders].
    Mémin Y; Najean Hueber E
    Therapeutique; 1973 Nov; 49(9):605-8. PubMed ID: 4600040
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical test of Iskedyl in cochlear and vestibular chronic diseases].
    Muler H; Prache H
    Ann Otolaryngol Chir Cervicofac; 1976; 93(4-5):325-7. PubMed ID: 821378
    [No Abstract]   [Full Text] [Related]  

  • 27. [Determinants estimating cerebral functions after long term therapy with hydergin].
    Herzfeld U; Christian W; Ronge J; Wittgen M
    Arztl Forsch; 1972 Jun; 26(6):215-28. PubMed ID: 4626216
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of chronic cerebrovascular insufficiency. Controlled comparative study of 2 cerebral antihypoxidosis agents].
    Szobor A; Klein M; Bräuer H
    MMW Munch Med Wochenschr; 1982 Oct; 124(41):897-900. PubMed ID: 6815511
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical studies on the effect of hexobendine (Ustimon) on cerebral circulatory disorders].
    Prosenz P; Tschabitscher H
    Wien Klin Wochenschr; 1965 Dec; 77(48):953-5. PubMed ID: 5331101
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative studies on prevention of thromboembolism using panthesin-hydergin].
    Schwalbe E; Fauner A
    Med Monatsschr; 1971 Apr; 25(4):185-8. PubMed ID: 4995458
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic cerebrovascular insufficiency in the elderly. Perspectives on treatment.
    Rosen HJ
    J Med Soc N J; 1972 May; 69(5):445-8. PubMed ID: 4623096
    [No Abstract]   [Full Text] [Related]  

  • 32. [Observations during ambulatory therapy of functional and organic circulatory disorders with Defluina].
    Brüning G
    Med Welt; 1975 Sep; 26(38):1737-41. PubMed ID: 810634
    [No Abstract]   [Full Text] [Related]  

  • 33. [The place of a peripheral vasodilator agent in the treatment of shock states].
    Lareng L; Jorda MF; Cathala B; Mathelin D
    Anesth Analg (Paris); 1974; 31(1):41-51. PubMed ID: 4210208
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinico-hemodynamic evaluation of the efficacy of vasoactive and cardiotonic agents in the combined treatment of arteriosclerosis patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Dorogiĭ AN; Nechaĭ EE; Shkrobot SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1313-20. PubMed ID: 3425072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
    Probst G; Keiser G
    Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566
    [No Abstract]   [Full Text] [Related]  

  • 36. [Attempt at psychometric evaluation of aging: study of a vascular drug].
    Losson M; Losson JP
    Therapeutique; 1969 Mar; 45(3):313-7. PubMed ID: 4989246
    [No Abstract]   [Full Text] [Related]  

  • 37. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
    Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
    [No Abstract]   [Full Text] [Related]  

  • 38. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
    Rao DB; Norris JR
    Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-term medical treatment of acute cerebrovascular disease sequelae (comparison papaverine-piribedil].
    Piccinelli A; Neri G; Agnoli A
    Minerva Med; 1974 Nov; 65(80):4199-213. PubMed ID: 4610451
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mental effects of Wallerox therapy in the aged].
    Thomae H
    Med Klin; 1970 Jun; 65(23):1132-4. PubMed ID: 5000216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.